Ruhm Christopher J
Frank Batten School of Leadership and Public Policy, University of Virginia, USA, P.O. Box 400893, Charlottesville, VA 22904-4893, United States.
National Bureau of Economic Research, Cambridge, MA, United States.
SSM Popul Health. 2017 Jan 31;3:219-226. doi: 10.1016/j.ssmph.2017.01.009. eCollection 2017 Dec.
Death certificate data from the Multiple Cause of Death (MCOD) files were analyzed to better understand the drug categories most responsible for the increase in fatal overdoses occurring between 1999 and 2014. Statistical adjustment methods were used to account for the understatement in reported drug involvement occurring because death certificates frequently do not specify which drugs were involved in the deaths. The frequency of combination drug use introduced additional uncertainty and so a distinction was made between versus drug involvement. Many results were sensitive to the starting and ending years chosen for examination. Opioid analgesics played a major role in the increased drug deaths for analysis windows starting in 1999 but other drugs, particularly heroin, became more significant for recent time periods. Combination drug use was important for all time periods and needs to be accounted for when designing policies to slow or reverse the increase in overdose deaths.
分析了多死因(MCOD)档案中的死亡证明数据,以更好地了解1999年至2014年间导致致命药物过量死亡人数增加的主要药物类别。采用统计调整方法来处理因死亡证明经常未指明死亡涉及哪些药物而导致报告的药物涉入情况被低估的问题。联合用药的频率带来了额外的不确定性,因此区分了单一药物与联合药物涉入情况。许多结果对所选的起始和结束年份很敏感。对于始于1999年的分析窗口,阿片类镇痛药在药物死亡增加中起主要作用,但其他药物,尤其是海洛因,在最近时期变得更为重要。联合用药在所有时期都很重要,在制定减缓或扭转药物过量死亡人数增加的政策时需要予以考虑。